PE anti-mouse CD200R (OX2R) Antibody
- 产品名称：
- PE anti-mouse CD200R (OX2R) Antibody
- 产品类别：
- 抗体
- 产品编号：
- 123907
- 产品应用：
- 123907
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Fusion protein mouse CD200RCD4d3
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Additional applications (for the relevant formats) include: in vivo studies3. The Ultra-LEAF? purified antibody is recommended for functional assays.
- Application References
(PubMed link indicates BioLegend citation) -
- Voulgaraki D, et al. 2005. Immunol. 115:337
- Stumper TL, et al. 2011. J. Immunol. 186:1970. PubMed
- Talebian F, et al. 2012. PLoS One 7:e31442. (FA)
- Product Citations
-
- Zhou J, et al. 2019. Immunity. 50:403. PubMed
- Stubelius A, et al. 2017. Immunobiology. 10.1016/j.imbio.2017.05.007. PubMed
- Sumpter T, et al. 2011. J Immunol. 186:1970. PubMed
- Flommersfeld S, et al. 2021. Immunity. :. PubMed
- McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed
- Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
- Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
- Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
- Najar M, et al. 2012. Immunol Lett. 146:50. PubMed
- Berrien–Elliott MM, et al. 2020. Immunity. 51(3):479-490. PubMed
- Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
- Nabekura T, et al. 2020. Immunity. 96:52. PubMed
- RRID
- AB_2074081 (BioLegend Cat. No. 123907) AB_2074080 (BioLegend Cat. No. 123908)
